InSysBio logo — Quantitative Systems Pharmacology modeling to support and op...

InSysBio

Quantitative Systems Pharmacology modeling to support and optimize drug R&D

Founded 2004 United Kingdom Edinburgh, United Kingdom 26 employees Biotechnology, Pharmaceutical

General Information

Company Name InSysBio
Founded Year 2004
Location United Kingdom Edinburgh, United Kingdom +3
Employees 26
Industries Biotechnology, Pharmaceutical
Social

Get notified when InSysBio moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About InSysBio

InSysBio is a Quantitative Systems Pharmacology (QSP) company established in 2004. The company focuses on providing customers with QSP modeling services and tools, leveraging its own cutting-edge methods and software infrastructure. InSysBio's approach involves reconstructing the effects of medication in terms of clinically measured biomarkers and end-points, predicting drug efficacy in humans based on data obtained in animals and in vitro studies, and identifying optimal combinational therapies. Over the years, it has successfully completed more than 100 projects in collaboration with industry leaders in the Biotechnology and Pharmaceutical sectors, positioning itself as a trusted partner in drug development. Additionally, the company offers educational assistance to academic entities. For more information about InSysBio, its solutions, services, and tools, visit www.insysbio.com.

Taxonomy: Quantitative Systems Pharmacology, Pharmacology Modeling, Drug Development, Personalized Medicine, Mathematical Modeling, PK/PD Modeling, PBPK/RO Modeling, Software Infrastructure, Educational Assistance, Biomarker Analysis, Combinational Therapies, Pharmaceutical Industry Collaboration, Academic Entity Support

No funding data available for InSysBio yet.

Get notified when InSysBio raises funding

InSysBio Alternatives & Competitors

InSysBio vs
RES Group, Inc
RES Group, Inc United States

Mechanistic modeling & simulation services to accelerate R&D in drug development

24 employees
Energy, Pharmaceutical
InSysBio vs

Cognigen Services is now a part of Simulations Plus, providing clinical pharmacology and pharmacomet...

34 employees
Biotechnology, Health Care
InSysBio vs
LYO-X AG
LYO-X AG Switzerland

PK/PD and Quantitative Systems Pharmacology for Biotherapeutics

11 employees

FAQ About InSysBio

Quantitative Systems Pharmacology modeling to support and optimize drug R&D
InSysBio was founded in 2004.
InSysBio is headquartered in Edinburgh, United Kingdom.
InSysBio operates in the following industries: Biotechnology, Pharmaceutical.
InSysBio has approximately 26 employees.
Top alternatives and competitors to InSysBio include RES Group, Inc, Cognigen Corporation, a division of Simulations Plus, LYO-X AG, Latvian Institute of Organic Synthesis, Softbuilder. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
InSysBio and RES Group, Inc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors InSysBio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy